NYSE:PG News 13 January 2026 - 23 January 2026

Procter & Gamble shares rose 0.2% to $150.28 in late morning trading Friday after a 2.7% jump Thursday. Quarterly net sales missed estimates at $22.21 billion, with U.S. volumes down 1%, but adjusted earnings beat forecasts. JPMorgan and Wells Fargo raised price targets, citing focus on U.S. volumes and upcoming policy guidance. The company cut its fiscal 2026 diluted earnings growth forecast to 1%–6%.

Procter & Gamble shares rose 2.7% to $149.93 in after-hours trading Thursday after reporting fiscal Q2 net sales of $22.2 billion, up 1%, and core EPS of $1.88, beating forecasts. Revenue missed estimates, but the company maintained its full-year outlook. Volumes fell 1% as pricing rose 1%. P&G returned $4.8 billion to shareholders through dividends and buybacks.

Procter & Gamble reported quarterly revenue of $22.21 billion, missing Wall Street estimates as volumes in core categories fell 1%. The company lowered its full-year net EPS growth outlook to 1%–6% due to higher restructuring charges but maintained its sales and core EPS targets. Beauty segment volumes rose 3%, while lower-income shoppers cut back on essentials. Operating cash flow reached $5.0 billion.

Procter & Gamble shares fell 0.6% to $146.06 Wednesday ahead of quarterly earnings due Thursday morning. Wall Street expects earnings of about $1.86 per share on $22.29 billion in revenue. Investors are watching for updates to full-year guidance, especially on costs and pricing. The company’s earnings call is set for 8:30 a.m. ET.

Procter & Gamble shares fell 0.7% to $145.94 Wednesday ahead of its quarterly results due Thursday. The stock had climbed 1.7% Tuesday, bucking a broader market selloff. Analysts expect Q2 revenue of $22.23 billion and earnings of $1.87 per share. P&G will host its earnings call Jan. 22 at 8:30 a.m. ET.

Procter & Gamble shares rose 1.71% to $147.00 Tuesday, defying a broad U.S. market selloff triggered by new tariff threats from President Trump. Trading volume surged above average as investors shifted into consumer staples. P&G remains about 18% below its 52-week high. Attention now turns to its January 22 earnings for updates on costs and demand.

Procter & Gamble shares rose 1.4% to $146.49 despite a broad market selloff triggered by new U.S. tariff threats on European imports. Barclays raised its price target to $155 but warned recent gains reflect defensive buying, not stronger fundamentals. Investors await P&G’s Jan. 22 earnings call for updates on pricing, costs, and demand. The Cboe Volatility Index hit an eight-week high as traders shifted to consumer staples.

Procter & Gamble shares slipped 0.1% to $144.53 Friday as U.S. markets closed nearly flat ahead of the long weekend. Barclays raised its price target for P&G to $155 but kept an Equal Weight rating. The company will report quarterly earnings and hold its call on Jan. 22. U.S. markets will be closed Monday for Martin Luther King Jr. Day.

Procter & Gamble closed Friday at $144.53, down 0.07%, as UBS maintained its buy rating but warned of a possible guidance cut next week. U.S. markets will stay shut Monday for Martin Luther King Jr. Day, reopening Tuesday. P&G reports fiscal Q2 earnings Jan. 22, with consensus at $1.87 EPS on $22.28 billion revenue. Options markets show heightened volatility expectations ahead of the release.

Procter & Gamble shares fell 0.6% to $143.76 Friday, extending losses for a second day. The company urged investors to reject a $100-per-share mini-tender offer from Potemkin Limited, calling it well below market value. P&G reports quarterly earnings January 22. UBS cut its price target to $161, citing sector headwinds.

Procter & Gamble shares rose 0.1% to $143.59 Tuesday, outperforming major index ETFs, which slipped up to 0.7%. Trading volume remained above average as investors awaited the Jan. 22 earnings call, the first under new CEO Shailesh Jejurikar. Monday marked the stock’s third straight gain. Inflation data and tariff costs continue to weigh on outlook.